National

Cambodia logs 3 more cases of mpox

Feb 12, 2024

Phnom Penh [Cambodia], February 12: Cambodia recorded three more cases of mpox, also known as monkeypox, raising the total number of infections in the kingdom to nine since last December, the Ministry of Health said in a statement on Sunday.
"Laboratory results from the National Institute of Public Health showed on Friday that three more persons tested positive for mpox, so the total confirmed cases of the disease in Cambodia have increased to nine," the ministry said.
The patients, who live in three different districts in the capital Phnom Penh, have been undergoing proper treatment at a hospital.
The ministry renewed calls on people to be extra vigilant, saying that mpox virus is transmitted from person to person through all forms of sexual contact with a person with mpox and through direct contact with wounds, body fluids, saliva, and equipment contaminated with the virus.
It added that mpox could be passed from mother to child through an umbilical cord during or after birth if a pregnant woman has the disease.
"Individuals with symptoms such as rash with blisters on the face, palms, feet, body, eyes, mouth or genitals, fever, swollen lymph nodes, headache, muscle aches, low back pain, and fatigue...should visit a health center or hospital for a consultation or test for mpox," the ministry said.
Citing a report from the World Health Organization (WHO), the ministry said that as of Jan. 25, a total of 93,030 confirmed cases of mpox, including 176 deaths, had been reported from 117 countries and regions.
Source: Xinhua

More news

Indian Research on Young-Onset Parkinson's Disease Receives Recognition at Global GP2 Conference

Bengaluru (Karnataka) [India], November 13: A study conducted by the Parkinson’s Research Alliance of India (PRAI) on the genetic basis of early-onset Parkinson’s disease (PD) in Indian patients has received international recognition as it won the “Best Poster” award at the Global Parkinson’s Genetics Program (GP2) Annual Conference held in Seoul, South Korea, in October 2026. The Global Parkinson’s Genetics Program (GP2), an initiative under Aligning Science Across Parkinson’s (ASAP), brings together researchers worldwide to advance the understanding of Parkinson’s disease genetics with a focus on populations historically underrepresented in research, and support globally relevant discoveries that can inform future therapeutic strategies.

Nov 13, 2026